The Dax continued its upward movement on Thursday. Numerous strong quarterly reports including increased annual targets supported. In addition, inflation data for Germany in January was slightly better than expected, although inflation is still very high. The leading German index rose by 1.26 percent in the morning to 15,605.51 points and thus also exceeded its high for the year on Thursday.
The Dax continued its upward movement on Thursday. Numerous strong quarterly reports including increased annual targets supported. In addition, inflation data for Germany in January was slightly better than expected, although inflation is still very high. The leading German index rose by 1.26 percent in the morning to 15,605.51 points and thus also exceeded its high for the year on Thursday.
The MDax of medium-sized stocks was hardly changed at minus 0.02 percent to 29,212.29 points. The Eurozone leading index EuroStoxx 50 advanced by 1.05 percent to 4253.26 points.
On the company side, investors focused on numerous quarterly reports and outlooks, which were overwhelmingly convincing. The technology group Siemens made a strong start to its new fiscal year 2022/23 and became more optimistic for the year as a whole. The digitization business was able to more than compensate for weaknesses in the train division and at the medical technology subsidiary Siemens Healthineers. The shares jumped to the top of the Dax with a plus of 7.1 percent.
Shares in Deutsche Börse rose by 1.5 percent. Brisk trading on the financial markets, the capers in the gas price, higher interest rates and acquisitions kept the Dax company on a record course. The operator of trading platforms earned more than ever last year, with business going better in all important areas.
Bayer stock went up and down. At first it went up significantly, most recently it fell by 0.5 percent. Earlier than planned, Bayer parted ways with the controversial boss Werner Baumann (60) and presented a successor on Wednesday afternoon: the ex-pharmaceutical boss of rival Roche, Bill Anderson (56), is to take over the helm from the beginning of June.
In the MDax, the papers of the biofuel manufacturer Verbio took the lead with a plus of 6.2 percent, while those of the food supplier Delivery Hero fell to the bottom with minus 8.2 percent. Verbio increased sales in the first half of the financial year, but was unable to fully pass on its costs to customers.
In the SDax, the papers of the shop pharmacy stood out with a minus of 6.5 percent. The Swiss bank Credit Suisse downgraded the share by two notches from “Outperform” to “Underperform”. The price target was capped from 75 to 42 euros.
Source: Stern
